Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosis

Leukemia Research

Volumn 37, Issue 1, 2013, Pages 32-36

  Diab, Adi ^a   Zickl, Lynette ^b   Abdel Wahab, Omar ^a   Jhanwar, Suresh ^a   Gulam, Manjit A ^a   Panageas, Katherine S ^a   Patel, Jay P ^a   Jurcic, Joseph ^a   Maslak, Peter ^a   Paietta, Elisabeth ^c   Mangan, James K ^e   Carroll, Martin ^e   Fernandez, Hugo F ^d   Teruya Feldstein, Julie ^a   Luger, Selina M ^e   Douer, Dan ^a   Litzow, Mark R ^f   Lazarus, Hillard M ^g   Rowe, Jacob M ^h   Levine, Ross L ^a   Tallman, Martin S ^a   more..

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f MAYO CLINIC   (United States)

^g UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^h SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

AML; APL; Leukemia; T(8; 16); Therapy related AML

Indexed keywords

ANTHRACYCLINE; BLEOMYCIN; CD11B ANTIGEN; CD14 ANTIGEN; CD15 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FIBRINOGEN; FLUOROURACIL; HLA DR ANTIGEN; METHOTREXATE; MYELOPEROXIDASE; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CELL TRANSFORMATION; CHILD; CHROMOSOME TRANSLOCATION 16; CHROMOSOME TRANSLOCATION 8; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROPHAGOCYTOSIS; FEMALE; GENE SEQUENCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH THROUGHPUT SEQUENCING; HISTIOCYTE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; INFANT; LEUKEMIA RELAPSE; LEUKOCYTE COUNT; MALE; MULTIPLE CYCLE TREATMENT; MUTATIONAL ANALYSIS; MYELOBLAST; NON SEMINOMATOUS GERMINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMYELOBLAST; PROMYELOCYTE; PROMYELOCYTIC LEUKEMIA; RUNX1 GENE; SEMINOMA; SKIN LEUKEMIA; SOMATIC MUTATION;

ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 8; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; TRANSLOCATION, GENETIC;

EID: 84870950950     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.08.025     Document Type: Article

References (28)

1. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. In: Mitelman F, Johansson B, Mertens F, editors; 2011, available at http://cgap.nci.nih.gov/Chromosomes/Mitelman.
2. Borrow J., Stanton V.P., Andresen J.M., Becher R., Behm F.G., Chaganti R.S., et al. The translocation t (8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 1996, 14:33-41.
3. Champagne N., Pelletier N., Yang X.J. The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase. Oncogene 2001, 20(3):404-409.
4. Huret J, Senon S. MYST3 (MYST histone acetyltransferase (monocytic leukemia) 3. In: Atlas Genet Cytogenet Oncol Haematol; 2005. URL:. http://atlasgeneticsoncology.org/Genes/MYST3ID25ch8p11.html.
5. Paietta E., Goloubeva O., Neuberg D., Bennett J.M., Gallagher R., Racevskis J., et al. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes. Cytometry B 2004, 59:1-9.
6. Kwann C.H. The pathophysiology of coagulopathy in APL. Clin Adv Hematol Oncol 2011, 9(2):7-9.
7. Stark B., Resnitzky P., Jeison M., Luria D., Blau O., Avigad S., et al. A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8:16)(p11:p13), in a patient with the variant t(8:19)(p11:q13)-case report and review of the literature. Leuk Res 1995, 19(6):367-379.
8. Rozman M., Camos M., Colomer D., Villamor N., Esteve J., Costa D., et al. Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation. Genes Chromosomes Cancer 2004, 40:140-145.
9. SEER Research. [accessed 10.02.11]. http://seer.cancer.gov/faststats.
10. Gervais C., Murati A., Helias C., Struski S., Eischen A., Lippertet, et al. Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogenetique hematologique. Leukemia 2008, 22:1567-1575.
11. Sainati L., Bolcato S., Cocito M.G., Zanesco L., Basso G., Montaldi A., et al. Transient acute monoblastic leukemia with reciprocal (8;16)(p11;p13) translocation. Pediatr Hematol Oncol 1996, 13:151-157.
12. Dinulos J.G., Hawkins D.S., Clark B.S., Francis J.S. Spontaneous remission of congenital leukemia. J Pediatr 1997, 131(2):300-303.
13. Classen C.F., Behnisch W., Reinhardt D., Koenig M., Möller P., Debatin K.M. Spontaneous complete and sustained remission of a rearrangement CBP (16p13)-positive disseminated congenital myelosarcoma. Ann Hematol 2005, 84:274-275.
14. Weintraub M., Kaplinsky C., Amariglio N., Rosner E., Brok-Simoni F., Rechavi G. Spontaneous regression of congenital leukaemia with an 8;16 translocation. Br J Haematol 2000, 111:641-643.
15. Rowe J.M., Tallman M.S. Intensifying induction therapy in acute myeloid leukemia: has a new standard of care emerged?. Blood 1997, 90:2121-2126.
16. Dohner H., Estey E.H., Amadori S., et al. Diagnosis and treatment of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European leukemiaNet. Blood 2010, 115:453-474.
17. Tasaka T., Matsuhashi Y., Uehara E., Tamura T., Kakazu N., Abe T., et al. Secondary acute monocytic leukemia with a translocation t(8;16)(p11;p13): case report and review of the literature. Leuk Lymphoma 2004, 45:621-625.
18. Quesnel B., Kantarjian H., Bjergaard J.P., Brault P., Estey E., Lai J.L., et al. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature. J Clin Oncol 1993, 11(12):2370-2379.
19. Haferlach T., Kohlmann A., Klein H.-U., Ruckert C., Dugas M., Williams P.M., et al. Cytogenetics and molecular genetics AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features. Leukemia 2009, 23:934-943.
20. Rowe J.M., Tallman M.S. How I treat acute myeloid leukemia. Blood 2010, 116(17):3147-3156.
21. Lekakis L., Giralt S., Couriel D., Shpall E.J., Hosing C., Khouri I.F., et al. Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies. Bone Marrow Transplant 2006, 38:421-426.
22. Craddock C.F. Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML. Bone Marrow Transplant 2008, 41:415-423.
23. Schmid C., Schleuning M., Ledderose G., Tischer J., Kolb H.J. Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol 2005, 23:5675-5687.
24. Goldstone A.H., Burnett A.K., Avivi I., et al. Secondary acute myeloid leukemia has a worse outcome than de novo AML, even taking into account cytogenetics and age: AML 10, 11, 12 MRC trials. Blood 2002, 100:88a. [abstr 322].
25. Kern W., Haferlach T., Schnittger S., Hiddemann W., Schoch C. Prognosis in therapy-related acute myeloid leukemia and impact of karyotype. J Clin Oncol 2004, 22:2510-2511.
26. Pulsoni A., Pagano L. Treatment of secondary acute myeloid leukemia. J Clin Oncol 2005, 23:926-927.
27. Rowe J.M. Therapy of secondary leukemia. Leukemia 2002, 16:748-750.
28. Bernasconi P., Orlandi E., Cavigliano P.M. Translocation (8;16) in a patient with acute myelomonocytic leukemia, occurring after treatment with fludarabine for a low-grade non-Hodgkin's lymphoma. Haematologica 2000, 85:1087-1091.